DK1915153T3 - Terapeutiske systemer med omgående frigivelse til forbedret oral absorption af 7-[(E)-tert-butyloxyiminomethyl]camptothecin - Google Patents
Terapeutiske systemer med omgående frigivelse til forbedret oral absorption af 7-[(E)-tert-butyloxyiminomethyl]camptothecinInfo
- Publication number
- DK1915153T3 DK1915153T3 DK06777710.2T DK06777710T DK1915153T3 DK 1915153 T3 DK1915153 T3 DK 1915153T3 DK 06777710 T DK06777710 T DK 06777710T DK 1915153 T3 DK1915153 T3 DK 1915153T3
- Authority
- DK
- Denmark
- Prior art keywords
- butyloxyiminomethyl
- camptothecin
- tert
- immediate release
- oral absorption
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000418A ITRM20050418A1 (it) | 2005-08-04 | 2005-08-04 | Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina. |
| PCT/EP2006/064111 WO2007017331A2 (en) | 2005-08-04 | 2006-07-11 | Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1915153T3 true DK1915153T3 (da) | 2013-06-24 |
Family
ID=37727667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06777710.2T DK1915153T3 (da) | 2005-08-04 | 2006-07-11 | Terapeutiske systemer med omgående frigivelse til forbedret oral absorption af 7-[(E)-tert-butyloxyiminomethyl]camptothecin |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20090053307A1 (enExample) |
| EP (1) | EP1915153B1 (enExample) |
| JP (1) | JP5225084B2 (enExample) |
| KR (1) | KR101301548B1 (enExample) |
| CN (1) | CN101287466B (enExample) |
| AU (1) | AU2006278114B2 (enExample) |
| BR (1) | BRPI0614471A2 (enExample) |
| CA (1) | CA2612080C (enExample) |
| CY (1) | CY1114311T1 (enExample) |
| DK (1) | DK1915153T3 (enExample) |
| ES (1) | ES2407408T3 (enExample) |
| HR (1) | HRP20130364T1 (enExample) |
| IT (1) | ITRM20050418A1 (enExample) |
| MX (1) | MX2008001029A (enExample) |
| PL (1) | PL1915153T3 (enExample) |
| PT (1) | PT1915153E (enExample) |
| RS (1) | RS52777B (enExample) |
| SI (1) | SI1915153T1 (enExample) |
| WO (1) | WO2007017331A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011002688A (es) | 2008-09-12 | 2011-04-12 | Critical Pharmaceuticals Ltd | Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel. |
| USD618617S1 (en) | 2008-12-30 | 2010-06-29 | Multiway Industries (Hk) Ltd. | Three way electrical plug |
| US7892036B2 (en) * | 2008-12-30 | 2011-02-22 | Multiway Industries (Hk) Ltd. | Electrical wall tap assembly |
| USD618175S1 (en) | 2009-10-15 | 2010-06-22 | Multiway Industries (Hk) Ltd. | Three-outlet surge-protected adaptor |
| USD616823S1 (en) | 2009-10-15 | 2010-06-01 | Multiway Industries (Hk) Ltd. | Single-outlet surge-protected adaptor |
| WO2011071194A1 (ko) * | 2009-12-08 | 2011-06-16 | 주식회사 일화 | 20-O-β-D-글루코피라노실-20(S)-프로토파낙사디올을 포함하는 고체분산체 |
| USD651977S1 (en) | 2011-01-10 | 2012-01-10 | Multiway Industries (Hk) Ltd. | Multiple outlet electrical connector |
| CN108066311B (zh) * | 2017-12-26 | 2020-09-08 | 兆科（广州）肿瘤药物有限公司 | 一种吉马替康胶囊及其制备方法 |
| USD958079S1 (en) | 2019-08-30 | 2022-07-19 | Multiway Industries (Hk) Ltd. | 3-way electrical tap |
| USD955993S1 (en) | 2019-08-30 | 2022-06-28 | Multiway Industries (Hk) Ltd. | 3-way electrical tap |
| CN111529497A (zh) * | 2020-02-11 | 2020-08-14 | 兆科（广州）肿瘤药物有限公司 | 一种吉马替康药物固体分散组合物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
| SI0999826T1 (en) * | 1997-07-29 | 2004-12-31 | Pharmacia & Upjohn Company | Self-emulsifying formulation for lipophilic compounds |
| AR013261A1 (es) * | 1997-08-01 | 2000-12-13 | Smithkline Beecham Corp | Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina |
| US7030155B2 (en) * | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| DK1044977T3 (da) * | 1999-03-09 | 2002-07-08 | Sigma Tau Ind Farmaceuti | Camptothecinderivater med antitumoraktivitet |
| KR20070058028A (ko) * | 1999-05-24 | 2007-06-07 | 소너스파머슈티칼즈인코포레이티드 | 난용성 약물용 에멀젼 부형제 |
| WO2005092302A2 (en) * | 2004-03-26 | 2005-10-06 | Novartis Ag | Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen |
| GT200500310A (es) * | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
| ES2395930T3 (es) * | 2004-12-21 | 2013-02-18 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Procedimiento estereoselectivo y formas cristalinas de una camptotecina |
-
2005
- 2005-08-04 IT IT000418A patent/ITRM20050418A1/it unknown
-
2006
- 2006-07-11 KR KR1020087003092A patent/KR101301548B1/ko not_active Expired - Fee Related
- 2006-07-11 CA CA2612080A patent/CA2612080C/en not_active Expired - Fee Related
- 2006-07-11 JP JP2008524462A patent/JP5225084B2/ja not_active Expired - Fee Related
- 2006-07-11 ES ES06777710T patent/ES2407408T3/es not_active Expired - Lifetime
- 2006-07-11 RS RS20130196A patent/RS52777B/sr unknown
- 2006-07-11 SI SI200631573T patent/SI1915153T1/sl unknown
- 2006-07-11 PL PL06777710T patent/PL1915153T3/pl unknown
- 2006-07-11 BR BRPI0614471-3A patent/BRPI0614471A2/pt not_active Application Discontinuation
- 2006-07-11 CN CN200680027844.9A patent/CN101287466B/zh not_active Expired - Lifetime
- 2006-07-11 AU AU2006278114A patent/AU2006278114B2/en not_active Ceased
- 2006-07-11 PT PT67777102T patent/PT1915153E/pt unknown
- 2006-07-11 US US11/993,328 patent/US20090053307A1/en not_active Abandoned
- 2006-07-11 MX MX2008001029A patent/MX2008001029A/es active IP Right Grant
- 2006-07-11 HR HRP20130364TT patent/HRP20130364T1/hr unknown
- 2006-07-11 DK DK06777710.2T patent/DK1915153T3/da active
- 2006-07-11 WO PCT/EP2006/064111 patent/WO2007017331A2/en not_active Ceased
- 2006-07-11 EP EP06777710.2A patent/EP1915153B1/en not_active Expired - Lifetime
-
2013
- 2013-04-25 CY CY20131100341T patent/CY1114311T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080031945A (ko) | 2008-04-11 |
| CN101287466B (zh) | 2014-11-05 |
| PT1915153E (pt) | 2013-06-05 |
| WO2007017331A2 (en) | 2007-02-15 |
| HRP20130364T1 (hr) | 2013-05-31 |
| AU2006278114A1 (en) | 2007-02-15 |
| SI1915153T1 (sl) | 2013-06-28 |
| AU2006278114B2 (en) | 2011-06-23 |
| BRPI0614471A2 (pt) | 2011-03-29 |
| MX2008001029A (es) | 2008-03-14 |
| HK1125293A1 (en) | 2009-08-07 |
| EP1915153B1 (en) | 2013-04-10 |
| ES2407408T3 (es) | 2013-06-12 |
| PL1915153T3 (pl) | 2013-09-30 |
| RS52777B (sr) | 2013-10-31 |
| JP2009503013A (ja) | 2009-01-29 |
| EP1915153A2 (en) | 2008-04-30 |
| CA2612080C (en) | 2013-09-03 |
| WO2007017331A3 (en) | 2007-09-27 |
| CN101287466A (zh) | 2008-10-15 |
| KR101301548B1 (ko) | 2013-09-06 |
| CY1114311T1 (el) | 2016-08-31 |
| ITRM20050418A1 (it) | 2007-02-05 |
| JP5225084B2 (ja) | 2013-07-03 |
| CA2612080A1 (en) | 2007-02-15 |
| US20090053307A1 (en) | 2009-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1924151T3 (da) | Oral frigivelsessystem med styret frigivelse | |
| DK1928503T3 (da) | Fremgangsmåde til fremstilling af oprensede lægemiddelkonjugater | |
| HUE054365T2 (hu) | Bór-ftalidok terápiás alkalmazásra | |
| MA28548B1 (fr) | Composes macrocycliques inhibiteurs de replication virale | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| DK2094676T3 (da) | Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater | |
| IL214617A (en) | Use of controlled release formulations of octreotide for the preparation of implants | |
| EP2046290A4 (en) | AQUEOUS DRONABINOL FORMULATIONS | |
| BRPI0719210A2 (pt) | Uso de compostos espiro-oxindol como agentes terapêuticos | |
| DK2046264T3 (da) | Fremgangsmåder til fremstillingen af sammensætninger med film | |
| DK2054073T3 (da) | Farmaceutiske præparater til fremføring med langvarig frigivelse af peptider | |
| DK1656347T3 (da) | Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme | |
| DK2402005T3 (da) | Formuleringer med langvarig frigivelse af nalbuphin | |
| DK2087890T3 (da) | Præparat med vedvarende frigørelse til vævsregenereringsterapi | |
| DK1937633T3 (da) | Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme | |
| DK1879844T3 (da) | Fremstilling af natriumdiformiat | |
| DK2146944T3 (da) | Fremgangsmåde til fremstillingen af 18f-mærkede folater | |
| CR9144A (es) | Formulaciones de benzoxazoles sustituidos | |
| NO20083139L (no) | Anvendelse av hyllebærekstrakt | |
| DK1957492T3 (da) | Substituerede bicykliske pyrimidonderivater | |
| EP1895991A4 (en) | MODIFIED RELEASE FORMULATIONS OF ANTI-IRRITABLE DRUGS | |
| ZA200608798B (en) | Macrocyclic compounds as inhibitors of viral replication | |
| NO20043305D0 (no) | Preparation of lodixanol | |
| PL1915153T3 (pl) | Systemy terapeutyczne o natychmiastowym uwalnianiu do ulepszonej doustnej absorpcji 7-[(E)-tertbutyloksyiminometylo]kamtotecyny | |
| EP1908786A4 (en) | 2-cyanoacrylate |